tiprankstipranks
Trending News
More News >
OpGen Inc (OPGN)
OTHER OTC:OPGN
Advertisement

OpGen (OPGN) Price & Analysis

Compare
597 Followers

OPGN Stock Chart & Stats


OpGen News

OPGN FAQ

What was OpGen Inc’s price range in the past 12 months?
OpGen Inc lowest stock price was $0.04 and its highest was $5.25 in the past 12 months.
    What is OpGen Inc’s market cap?
    OpGen Inc’s market cap is $395.68K.
      When is OpGen Inc’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were OpGen Inc’s earnings last quarter?
      OpGen Inc released its earnings results on Aug 08, 2024. The company reported -$1.176 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.176.
        Is OpGen Inc overvalued?
        According to Wall Street analysts OpGen Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does OpGen Inc pay dividends?
          OpGen Inc does not currently pay dividends.
          What is OpGen Inc’s EPS estimate?
          OpGen Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does OpGen Inc have?
          OpGen Inc has 10,068,111 shares outstanding.
            What happened to OpGen Inc’s price movement after its last earnings report?
            OpGen Inc reported an EPS of -$1.176 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -12.5%.
              Which hedge fund is a major shareholder of OpGen Inc?
              Currently, no hedge funds are holding shares in OPGN

              Company Description

              OpGen Inc

              OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.

              OpGen (OPGN) Earnings & Revenues

              Similar Stocks
              Company
              Price & Change
              Follow
              VolitionRX
              Precipio
              BioNano Genomics
              Burning Rock Biotech
              Biodesix

              Ownership Overview

              26.81%73.19%
              26.81% Insiders
              ― Other Institutional Investors
              73.19% Public Companies and
              Individual Investors

              Options Prices

              Currently, No data available
              ---
              Popular Stocks
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis